Menu
Sector
Investment stage
Source
Therapeutics
Investment amount
£25.5m
Investment share
14.0%
Source
Imperial College London
Investment stage
Listed

A clinical-stage specialty biopharmaceutical company developing a range ...

Find out more
Engineering & Materials
Investment amount
£22.4m
Investment share
40.0%
Source
Imperial College London
Investment stage
post-Series A

Unique silicon anodes for next generation Lithium-ion batteries ...

Find out more
Medtech
Investment amount
£13.7m
Investment share
48.2%
Source
Imperial College London
Investment stage
post-Series A

3D stent technology intended to improve the biomechanical ...

Find out more
Therapeutics
Investment amount
£12.3m
Investment share
27.0%
Source
Imperial College London
Investment stage
post-Series A

Developing cell based products for immune reconstitution and ...

Find out more
Therapeutics
Investment amount
£10.5m
Investment share
23.6%
Source
Imperial College London
Investment stage
Listed

Services and technologies to enable the development of ...

Find out more
Therapeutics
Investment amount
£9.5m
Investment share
28.5%
Source
University of Oxford
Investment stage
post-Series A

Innovative therapeutics for serious diseases with a particular ...

Find out more
Engineering & Materials
Investment amount
£9.0m
Investment share
45.7%
Source
Imperial College London
Investment stage
post-Series A

Focused on the production of next generation biopolymers ...

Find out more
Medtech
Investment amount
£7.6m
Investment share
4.6%
Source
University of Oxford
Investment stage
Listed

Novel diagnostic tests based on T-cell measurement technology

Find out more
Engineering & Materials
Investment amount
£4.4m
Investment share
56.1%
Source
Imperial College London
Investment stage
post-Series A

Copolymerisation catalysts that blend CO2 with epoxides, producing ...

Find out more
Therapeutics
Investment amount
£5.0m
Investment share
25.7%
Source
University College London
Investment stage
post-Series A

Pioneering the development of novel therapeutics for the ...

Find out more
Therapeutics
Investment amount
£5.8m
Investment share
21.2%
Source
University of Cambridge
Investment stage
post-Series A

Cancer therapeutics based on new understandings of DNA ...

Find out more
Therapeutics
Investment amount
£5.9m
Investment share
33.1%
Source
Imperial College London
Investment stage
post-Series A

Developing novel small molecule medicines as topical treatments ...

Find out more
ICT/Digital
Investment amount
£5.6m
Investment share
30.0%
Source
Imperial College London
Investment stage
post-Series A

Developing bio-inspired vision system enabling intelligent image recognition

Find out more
Medtech
Investment amount
£5.8m
Investment share
35.5%
Source
Imperial College London
Investment stage
post-Series A

Developer and distributer of state-of-the-art diagnostic tools and ...

Find out more
Engineering & Materials
Investment amount
£3.3m
Investment share
34.1%
Source
Imperial College London
Investment stage
post-Series A

Axial Flux motors and generators for automotive and ...

Find out more
Engineering & Materials
Investment amount
£1.2m
Investment share
9.0%
Source
University of Cambridge
Investment stage
Series A

Self-organizing small-cell microwave backhaul

Find out more
Therapeutics
Investment amount
£3.3m
Investment share
17.4%
Source
Babraham Institute
Investment stage
post-Series A

Differentiated medicines through unique transgenic antibody fragment platform

Find out more
Medtech
Investment amount
£5.0m
Investment share
16.4%
Source
University College London
Investment stage
post-Series A

Innovative orthopaedic business focused on patient specific primary ...

Find out more
ICT/Digital
Investment amount
2.0m
Investment share
36.2%
Source
Imperial College London
Investment stage
Series A

Mobile payments with integrated loyalty schemes

Find out more
ICT/Digital
Investment amount
£2.4m
Investment share
27.7%
Source
University of Cambridge
Investment stage
post-Series A

Leading predictive analytics company

Find out more
ICT/Digital
Investment amount
0
Investment share
23.3%
Source
Imperial College London
Investment stage
IP Equity

Leading supplier of advanced process modeling software & ...

Find out more
Therapeutics
Investment amount
£1.85m
Investment share
48.4%
Source
Imperial College London
Investment stage
Seed

Oncology drug discovery

Find out more
Therapeutics
Investment amount
£1.8m
Investment share
25.0%
Source
Imperial College London
Investment stage
post-Series A

Generating anti-infective agents to treat RSV & Aspergillus

Find out more
Engineering & Materials
Investment amount
£1.6m
Investment share
34.5%
Source
University of Cambridge
Investment stage
Seed

Developing unique solutions for encapsulation based on cutting-edge ...

Find out more
Medtech
Investment amount
£1.0m
Investment share
28.8%
Source
University of Cambridge
Investment stage
Seed

Live, online cognitive behavioural therapy

Find out more
Engineering & Materials
Investment amount
£3.0m
Investment share
59.9%
Source
Imperial College London

Advanced high-temperature metal forming technologies that enable cost-effective ...

Find out more
Engineering & Materials
Investment amount
0
Investment share
26.0%
Source
Imperial College London
Investment stage
IP Equity

Experts in remote monitoring solutions for the oil ...

Find out more
Medtech
Investment amount
£0.8m
Investment share
27.3%
Source
Cancer Research UK
Investment stage
Seed

Clinical cancer genomics company utilising circulating DNA analysis ...

Find out more
Engineering & Materials
Investment amount
£0.6m
Investment share
35.3%
Source
University of Oxford
Investment stage
Seed

Developing enzymatic process technologies that yield high value ...

Find out more
Medtech
Investment amount
£1.0m
Investment share
11.5%
Source
Imperial College London
Investment stage
Listed

Medical imaging services and rapid diagnostics

Find out more
Therapeutics
Investment amount
£0.2m
Investment share
16.0%
Source
University College London
Investment stage
Seed

Engineering & Materials
Investment amount
£0.3m
Investment share
37.9%
Source
Imperial College London
Investment stage
Seed

Sub-Salt’s mission is to develop a step-change in ...

Find out more
Therapeutics
Investment amount
£2m
Investment share
37.9%
Source
Other
Investment stage
post-Series A

Novel disease modifying medications for respiratory disease

Find out more
Therapeutics
Investment share
27.5%
Source
Other

Novel anti-infectives to overcome antibiotic resistance

Find out more
ICT/Digital
Investment amount
£3.0m
Investment share
28.6%
Source
Other
Investment stage
Series A

Internet of Things solutions provider specialising in fully ...

Find out more
ICT/Digital
Investment amount
£1m
Investment share
42.5%
Source
Imperial College London
Investment stage
Seed

Water flow and pipe health analytics

Find out more